Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Inge Oudaert actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
-
FWOTM970: Hypoxie-geïnduceerde metabole veranderingen als target in multipel myeloom om drug resistentie te overwinnen.
1/10/19 → 31/10/21
Project: Fundamenteel
-
Targeting the hypoxia-induced metabolic changes in myeloma to conquer drug resistance
Oudaert, I., 2023, (Unpublished) Brussels.Onderzoeksoutput: PhD Thesis
-
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma
Oudaert, I., Van der Vreken, A., Maes, A., De Bruyne, E., De Veirman, K., Vanderkerken, K. & Menu, E., 1 sep 2022, In: Experimental Hematology and Oncology. 11, 1, 19 blz., 49.Onderzoeksoutput: Article › peer review
Open Access -
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Oudaert, I., Satilmis, H., Vlummens, P., De Brouwer, W., Maes, A., Hose, D., De Bruyne, E., Ghesquière, B., Vanderkerken, K., De Veirman, K. & Menu, E., 1 feb 2022, In: Journal of Experimental & Clinical Cancer Research. 41, 1, blz. 45 17 blz., 45.Onderzoeksoutput: Article › peer review
Open Access5 Citaten (Scopus) -
System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance
Wang, F., Oudaert, I., Tu, C., Maes, A., Van der Vreken, A., Vlummens, P., De Bruyne, E., De Veirman, K., Wang, Y., Fan, R., Massie, A., Vanderkerken, K., Shang, P. & Menu, E., jun 2022, In: Cancer Letters. 535, 215649.Onderzoeksoutput: Article › peer review
Open Access4 Citaten (Scopus) -
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma
Zaal, E., De Groot, H. J., Oudaert, I., Menu, E. & Berkers, C. R., 1 jan 2022, In: Molecular Omics. 18, 1, blz. 19-30 12 blz.Onderzoeksoutput: Article › peer review
Open Access
Prijzen
-
ASH abstract achievement award
Oudaert, Inge (Recipient), 12 dec 2021
Prijs: Prize (including medals and awards)
-
-
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Oudaert, Inge (Recipient), Menu, Eline (Recipient) & Van Droogenbroeck, L. (Recipient), 3 mrt 2021
Prijs: Prize (including medals and awards)
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Oudaert, Inge (Recipient) & Menu, Eline (Recipient), 29 jan 2021
Prijs: Prize (including medals and awards)
Activiteiten
-
-
European Myeloma network meeting 2021
Inge Oudaert (Participant)
3 mrt 2021 → 6 mrt 2021Activiteit: Participation in conference
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker), Eline Menu (Contributor) & Kim De Veirman (Contributor)
29 jan 2021 → 30 jan 2021Activiteit: Talk or presentation at a conference
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Inge Oudaert (Contributor), Eline Menu (Presenter) & Lauren Van Droogenbroeck (Presenter)
3 mrt 2021 → 6 mrt 2021Activiteit: Talk or presentation at a conference
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker) & Eline Menu (Speaker)
29 jan 2021Activiteit: Talk or presentation at a conference
Bestand
Scriptie
-
Targeting the hypoxia-induced metabolic changes in myeloma to conquer drug resistance
Auteur: Menu, E. & Oudaert, I., 2023Scriptie/Masterproef: Doctoral Thesis
-
Upregulation of acid sphingomyelinase in exosomes contributes to multiple myeloma drug resistance
Auteur: Oudaert, I., Menu, E. & Faict, S., 2020Begeleider: Menu, E. (Promotor) & Faict, S. (Advisor)
Scriptie/Masterproef: Master's Thesis